Quantcast

Latest Lactams Stories

2014-05-28 08:30:29

Companies anticipate providing over-the-counter (OTC) product to treat erectile dysfunction after expiration of certain patents PARIS and INDIANAPOLIS, May 28, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Eli Lilly and Company (NYSE: LLY) today announced an agreement to pursue regulatory approval of nonprescription Cialis (tadalafil). Cialis is currently available by prescription only worldwide for the treatment of men with erectile dysfunction (ED). Under the terms of the...

2014-05-27 23:02:45

The Firm has filed a number of Risperdal lawsuits in the Pennsylvania proceeding on behalf of clients who allegedly developed gynecomastia (male breast growth) due to their use of Risperdal. New York, New York (PRWEB) May 27, 2014 As Risperdal lawsuits (http://www.injurybeacon.com/risperdal/lawsuit/) continue to mount in a mass tort litigation underway in Pennsylvania’s Philadelphia Court of Common Pleas, Bernstein Liebhard LLP notes that the defense is seeking partial summary judgment...

2014-05-24 23:02:58

Ashley Brittain Landers of Schlichter, Bogard & Denton, LLP reports that a new study published in JAMA Internal Medicine in April 2014 suggests that there may be a potential link between sildenafil (the active ingredient in Viagra, a drug used to treat erectile dysfunction in men) and melanoma, a deadly form of skin cancer. St. Louis, MO (PRWEB) May 24, 2014 A recent article published by JAMA Internal Medicine in April 2014 evaluated the association between sildenafil use and the risk...

2014-05-22 23:13:01

Recent motions in Pennsylvania courts mark progress for Risperdal gynecomastia lawsuits; Risperdal lawyers offer no-obligation Risperdal gynecomastia lawsuit case review. St. Louis, MO (PRWEB) May 22, 2014 Attorneys handling national Risperdal lawsuits for The Onder Law Firm report progress in the Risperdal lawsuits filed in Pennsylvania’s Complex Litigation Center. According to court documents*, a Motion for Summary Judgment regarding Statute of Limitations was filed earlier this...

2014-05-21 10:57:55

University of Montreal Chemists develop new approach to detect counterfeit medicines such as Viagra Researchers at the University of Montreal have developed an improved chemical analysis method that is more efficient and faster in detecting counterfeit medicines, which have skyrocketed in recent years. The method was developed and tested in a study by Philippe Lebel, Alexandra Furtos and Karen Waldron of the university's Department of Chemistry. It identifies and quantifies the various...

2014-05-20 08:34:22

AADi Initiates NIH Funded Clinical Trial for Patients with Bladder Cancer PACIFIC PALISADES, Calif., May 20, 2014 /PRNewswire/ -- AADi, LLC, a clinical stage biopharmaceutical company focused on treating diseases uniquely suited for nanotechnology approaches, today announced the inlicensing of ABI-009 from Celgene Corporation (NASDAQ:CELG). ABI-009 is the nanoparticle albumin-bound (nab®) version of the mTOR inhibitor sirolimus or rapamycin and leverages the same technology of the...

2014-05-19 11:34:54

Johns Hopkins Medicine New animal studies by Johns Hopkins cardiovascular researchers strongly suggest that sildenafil, the erectile dysfunction drug sold as Viagra and now under consideration as a treatment for heart failure, affects males and females very differently. The results of their investigations in varied male and female mouse models of heart failure are so clear-cut, says lead scientist Eiki Takimoto, M.D., Ph.D., that physicians may need to take gender into consideration...

2014-05-18 12:20:18

Panel discusses changes in a man's sexual function after a bilateral nerve-sparing radical prostatectomy and in those with LUTS/BPH ORLANDO, Fla., May 18, 2014 /PRNewswire-USNewswire/ -- Two studies evaluating the sexual function in men with Lower Urinary Tract Symptoms (LUTS) as well as post bilateral nerve-sparing radical prostatectomy will be presented to the media at a special press conference during the 2014 Annual Scientific Meeting of the American Urological Association (AUA). Tobias...

2014-05-13 23:02:34

The Firm is representing Risperdal lawsuit clients who allegedly developed gynecomastia (male breast growth) due to their use of the antipsychotic drug. New York, New York (PRWEB) May 13, 2014 The Pennsylvania judge overseeing hundreds of Risperdal lawsuits (http://www.risperdallawsuitcenter.com/) in the Philadelphia Court of Common Pleas has granted a defense motion to bar plaintiffs from seeking punitive damages. In an Order issued on May 2, 2014 Judge Arnold New ruled that the New...

2014-05-13 08:33:18

New submission based on positive data from a 15-month schizoaffective relapse prevention study TITUSVILLE, N.J., May 13, 2014 /PRNewswire/ -- Janssen Pharmaceuticals, Inc., today announced the submission of supplemental New Drug Applications (sNDAs) for once-monthly atypical long-acting antipsychotic INVEGA(®) SUSTENNA(®) (paliperidone palmitate) to the U.S. Food and Drug Administration (FDA) for approval to treat schizoaffective disorder as either monotherapy or adjunctive...


Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related